Teva Canada Limited
Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., is a leading player in the Canadian pharmaceutical industry, headquartered in CA. Established in 2000, the company has made significant strides in providing high-quality generic and specialty medications across various therapeutic areas, including pain management, respiratory health, and central nervous system disorders. With a robust portfolio of over 300 products, Teva Canada is renowned for its commitment to innovation and accessibility, ensuring that essential medications are available to Canadians. The company has achieved notable milestones, including the introduction of several first-to-market generics, solidifying its position as a trusted provider in the healthcare sector. Teva Canada continues to focus on improving patient outcomes while maintaining a strong market presence through its dedication to quality and affordability.
DitchCarbon Score
How does Teva Canada Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Teva Canada Limited's score of 82 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Teva Canada Limited currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Teva Pharmaceutical Industries Limited, which may influence its climate commitments and emissions reporting. Teva Pharmaceutical Industries Limited, the parent company, has established various climate initiatives and targets that cascade down to Teva Canada Limited. However, specific reduction targets or achievements for Teva Canada are not detailed in the available information. The parent company is involved in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which guide its overall climate strategy. As a part of its commitment to sustainability, Teva Canada Limited aligns with the broader goals set by its parent company, focusing on reducing carbon emissions and enhancing environmental performance. However, without specific emissions data or reduction targets, the precise impact of these initiatives at the subsidiary level remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 438,420,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 613,541,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Teva Canada Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
